Search
for
Sort by
Research 241–270 of 820
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Development of finasteride/PHBV@polyvinyl alcohol/chitosan reservoir-type microspheres as a potential embolic agent: from <i>in vitro</i> evaluation to animal study
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Antiandrogen therapy for androgenetic alopecia
- The concealed side of caspases: beyond a killer of cells
- KY19382, a novel activator of Wnt/β‐catenin signalling, promotes hair regrowth and hair follicle neogenesis
- Histopathologic diagnosis of multifactorial alopecia
- The evolution of primary multimodality treatment in resectable breast cancer
- The current state of play in the histopathologic assessment of alopecia: two for one or one for two?
- A SIMPLIFIED APPROACH TO THE DIAGNOSIS OF ALOPECIA
- ACUTE ZINC DEPLETION SYNDROME DURING PARENTERAL HYPERALIMENTATION
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Regeneration of hair and other skin appendages: A microenvironment‐centric view
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Association of male pattern baldness with angiographic coronary artery disease severity and collateral development
- Localization of Cathepsins B, D, L, LAMP-1 and .MU.-Calpain in Developing Hair Follicles.
- Clinical Development of Topoisomerase-Interactive Drugs
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- Polycystic ovary syndrome
- Profound bradycardia after addition of diltiazem to a beta blocker.
- Should we consider alternative therapies to operative hysteroscopy for the treatment of Asherman syndrome?
- Types and Treatment of Hair Loss in Men and Women
- Fatal autoimmunity results from the conditional deletion of Snai2 and Snai3
- Vitamin D and platelet Rich Plasma (PRP) in the treatment of vitiligo
- Wear characteristics of epoxy based hybrid composites reinforced with short hair fibers and glass micro spheres
- Secretory phospholipase A2-IIA overexpressing mice exhibit cyclic alopecia mediated through aberrant hair shaft differentiation and impaired wound healing response
- Minimal Incision Face-Lifting